Boehringer Challenges Medicare Drug Price Negotiation Law

By Aaron Keller · August 21, 2023, 4:27 PM EDT

Boehringer Ingelheim Pharmaceuticals Inc. has filed another in a string of constitutional challenges to the Inflation Reduction Act, arguing that the U.S. Department of Health and Human Services is derailing drug...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Boehringer Ingelheim Pharmaceuticals, Inc. v. United States Department of Health and Human Services et al

Case Number

3:23-cv-01103

Court

Connecticut

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

August 18, 2023

Recent Articles By Aaron

July 12, 2024
Conn. Health Staffing Co. Co-Owner Drops Partnership Suit
June 12, 2024
Yale Hospital OK With Merging Suits Over Stalled $435M Sale
June 12, 2024
Conn. Justices Nix Health Dept. Worker's Whistleblower Claim
June 07, 2024
Yale Hospital Sued For Seeking To Exit $435M Purchase Deal
May 29, 2024
Conn. Hospital Settles Exonerated Doctor's Race Bias Suit
May 21, 2024
2nd Circ. Partially Backs Win For Nurses' Union Pension Plan
April 29, 2024
Conn. Health Co., Competitor Eye Deal In Trade Secrets Suit
April 19, 2024
Sentence For Pandemic Funds Theft Seems To Split 2nd Circ.
February 22, 2024
Conn. AG Defends $10M Remedy Bid Against Nursing School
February 09, 2024
Conn. Judge Guts Healthcare Staffing Co. Partnership Suit